title: Canada's Patented Medicines (Notice of Compliance) Proceedings and Intellectual Property.
abstract: Canada's Patent Register is a tool created by the Patented Medicines (Notice of Compliance) Regulations to help innovators protect their inventions relating to pharmaceuticals. This tool exists at the intersection between the intellectual property and drug approval regimes. By listing a patent on the Patent Register, an innovator can prevent a generic manufacturer from entering the marketplace rather than having to wait for his or her patent to be infringed. This article provides information on the requirements for listing a patent on the Patent Register and an overview of how the Patent Medicines (Notice of Compliance) Regulations affect the drug approval process.
authors.affiliation: Intellectual Property Group, Torys LLP, Toronto, Ontario M5K 1N2, Canada.
authors.forename: Henry
authors.initials: H
authors.lastname: Bian
authors.affiliation: Intellectual Property Group, Torys LLP, Toronto, Ontario M5K 1N2, Canada.
authors.forename: Conor
authors.initials: C
authors.lastname: McCourt
mesh_terms: D002170:Canada; D016568:Drugs, Generic; D018973:Intellectual Property; D007880:Legislation, Drug; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D004364:Pharmaceutical Preparations; D012042:Registries
chemical_list: D016568:Drugs, Generic; D004364:Pharmaceutical Preparations